RISK DRIVERS OF FALSIFIED AND SUB-STANDARD MEDICINES IN EAST AFRICA: PERCEPTIONS AND PRACTICES OF PHARMACEUTICAL DRUG FACILITY OWNERS/EMPLOYEES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2014, Vol 2, Issue 3
Abstract
An interview survey was conducted among drug shop owners to investigate the access to and perception of counterfeit medication along transport corridors of East Africa spanning Kenya, Tanzania, Uganda and Democratic Republic of Congo. Owners of 171 retail drug outlets of modern medicines were interviewed on their knowledge, perception, and practices related to counterfeit medicines. Forty-four (44) encounters with counterfeit medicines were reported. Twenty-two (22) of the 171 interviewed drug store owners said that quality was the least important aspect they considered when procuring drugs. Generally, 65.9% of the drugs were sourced from registered wholesalers and distributors while the remaining 34.1% were supplied by unregistered in-country or cross-border sales representatives. In all the four countries, the 10 fastest moving drugs were reported to originate from 27 different countries with most (39%) from India. From 171 interviewees, 135 acknowledged that they were aware of the existence of counterfeit drugs, 106 of whom attributed their level of awareness to mass media. Only 32 of the interviewees reported having received any formal training on counterfeit medicines at seminars or workshops. 160 of the interviewees acknowledged that counterfeit drugs pose a major threat to the patient and pharmaceutical market. The region has a plethora of drug outlets run by attendants with varying backgrounds, diverse knowledge on medicines and practice patterns. There is an urgent need for medicine regulators and other stakeholders in Africa involved in medicine safety, to focus on properly regulating these outlets and also standardizing and training the drug outlet personnel.
Authors and Affiliations
Fomundam Henry, Tesfay A, Maranga A, Oyaro F, Kambafwile H.
Keywords
Related Articles
- EP ID EP349814
- DOI 10.22270/ijdra.v2i3.9
- Views 107
- Downloads 0
DRUG REGULATION IN INDIA: SWOT ANALYSIS
Drug regulation plays pivotal role in any country because the purpose of drug regulation is to promote and to protect public health by ensuring the safety, efficacy and quality of drugs. Drug regulation should cover all...
TECHNOLOGY DVELOPMENT FOR POLYMER MODIFICATION TO ENHANCE SOLUBILITY OF POORLY SOLUBLE DRUG
Solubilization of poorly soluble drugs is a frequently encountered challenge in screening studies of new chemical entities as well as in formulation design and development. Solubility of some drugs is very less; these dr...
SELF-MEDICATION IN RELATION TO HEALTH LOCUS OF CONTROL
Present study was conducted to examine the association of self- medication and health locus of control. It was also intended to know the health problems for which people do self – medication and the medicines which are m...
NUTRACEUTICALS - A REGULATORY REVIEW
The Nutraceuticals are the emerging sector in the Pharma Industry. As people are more and more concerned about their health and diseases caused by the malnutrition, the growth of the Nutraceuticals worldwide are inevitab...
Preliminary requirement for ANDA Filing
USFDA is very critical regulated agency for submission. This review reveals how to submit an Abbreviated New Drug Application (ANDA) as per FDA under section 505(j) of the Federal Food, Drug, and Cosmetic Act (FD&C Act)...